Page last updated: 2024-11-08

Tetrahydropiperine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID581676
CHEMBL ID332479
CHEBI ID184110
SCHEMBL ID4898699

Synonyms (36)

Synonym
23434-88-0
CHEMBL332479 ,
5-(3,4-methylenedioxyphenyl) pentanoicacid piperidine amide
5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpentan-1-one
tetrahydropiperine
CHEBI:184110
bdbm50381233
piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxopentyl)-
1-pentanone, 5-(1,3-benzodioxol-5-yl)-1-(1-piperidinyl)-
8904do502t ,
piperidine, 1-(5-(3,4-(methylenedioxy)phenyl)valeryl)-
cosmoperine
unii-8904do502t
tetrahydropiperidine
S5154
tetrahydropiperine [inci]
SCHEMBL4898699
piperidine, 1-[5-(1,3-benzodioxol-5-yl)-1-oxopentyl]-
1-[5-(1,3-benzodioxol-5-yl)pentanoyl]piperidine #
DTXSID00177988
tetrahydropiperin
AKOS030631903
5-(3,4-methylenedioxyphenyl)-pentanoylpiperidine
5-(1,3-benzodioxol-5-yl)-1-(1-piperidinyl)-1-pentanone
HY-N4205
E77130
HMS3886A15
CCG-267372
FT-0777293
Q27269974
CS-0032425
BS-51886
5-(benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)pentan-1-one
YAA43488
5-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)pentan-1-one
AC-34775
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzodioxoles
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)EC50 (µMol)6.30960.00051.06746.3096AID478379
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (37)

Processvia Protein(s)Taxonomy
thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
fever generationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
microglial cell activationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
diet induced thermogenesisTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
peptide secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of systemic arterial blood pressureTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
lipid metabolic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chemosensory behaviorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of heart rateTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of mitochondrial membrane potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
glutamate secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to heatTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of apoptotic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to peptide hormoneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
behavioral response to painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
sensory perception of mechanical stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory postsynaptic potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
smooth muscle contraction involved in micturitionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to alkaloidTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to ATPTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to tumor necrosis factorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to acidic pHTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to temperature stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of establishment of blood-brain barrierTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to capsazepineTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to nerve growth factor stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (15)

Processvia Protein(s)Taxonomy
transmembrane signaling receptor activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
voltage-gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
ATP bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chloride channel regulator activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphatidylinositol bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphoprotein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
temperature-gated ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
external side of plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
dendritic spine membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
neuronal cell bodyTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
postsynaptic membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID389756Inhibition of NorA efflux pump in Staphylococcus aureus 1199 assessed as fold reduction of ciprofloxacin MIC at 50 ug/ml2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
AID478381Agonist activity at human TRPV1 expressed in tetracycline-stimulated HEK293 cells assessed as increase in intracellular calcium levels by fluorimetric assay relative to control2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
In vitro TRPV1 activity of piperine derived amides.
AID657238Inhibition of MAO-B in Sprague-Dawley rat brain homogenate using kynuramine as substrate preincubated for 10 mins measured by fluorimetric assay2012Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
Synthesis and inhibitory effect of piperine derivates on monoamine oxidase.
AID436581Inhibition of NorA efflux pump in Staphylococcus aureus 1199B assessed as potentiation of ciprofloxacin-induced antimicrobial activity after 24 hrs by broth checkerboard method2009European journal of medicinal chemistry, Oct, Volume: 44, Issue:10
Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.
AID478379Agonist activity at human TRPV1 expressed in tetracycline-stimulated HEK293 cells assessed as increase in intracellular calcium levels by fluorimetric assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
In vitro TRPV1 activity of piperine derived amides.
AID436579Inhibition of NorA efflux pump in Staphylococcus aureus 1199B assessed as accumulation of ethidium bromide after 24 hrs by broth checkerboard method2009European journal of medicinal chemistry, Oct, Volume: 44, Issue:10
Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.
AID657237Inhibition of MAO-A in Sprague-Dawley rat brain homogenate using kynuramine as substrate preincubated for 10 mins measured by fluorimetric assay2012Bioorganic & medicinal chemistry letters, May-01, Volume: 22, Issue:9
Synthesis and inhibitory effect of piperine derivates on monoamine oxidase.
AID478380Agonist activity at human TRPV1 expressed in HEK293 cells assessed as increase in intracellular calcium levels by fluorimetric assay without tetracycline-stimulation2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
In vitro TRPV1 activity of piperine derived amides.
AID389747Inhibition of NorA efflux pump in Staphylococcus aureus 1199B assessed as fold reduction of ciprofloxacin MIC at 50 ug/ml2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
AID213669In vitro growth inhibition of epimastigotes of Trypanosoma cruzi2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi.
AID213667In vitro growth inhibition of amastigotes of Trypanosoma cruzi2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi.
AID436580Inhibition of NorA efflux pump in Staphylococcus aureus 1199B assessed as reduction of ciprofloxacin MIC after 24 hrs by broth checkerboard method2009European journal of medicinal chemistry, Oct, Volume: 44, Issue:10
Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.
AID496817Antimicrobial activity against Trypanosoma cruzi2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.34 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index39.41 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]